Use App
Trending
News
Earnings
All
DIA
0.48%
SPY
0.10%
QQQ
1.12%
Trending
MRK
0.45%
JNJ
1.59%
DOGE
0.02%
CCXI
5.00%
XCN
1.34%
XRP
1.86%
VG
5.61%
TSLL
4.38%
ETH
1.47%
RIG
0.56%
MRK
0.45%
JNJ
1.59%
DOGE
0.02%
CCXI
5.00%
XCN
1.34%
XRP
1.86%
VG
5.61%
TSLL
4.38%
ETH
1.47%
RIG
0.56%
Feed
News
Sentiment
Fundamentals
Info
home
Symbol
LLYX
news
Exchange:
NYSEArca
·
Updated 07:59 PM EDT
LLYX
Defiance Daily Target 2X Long LLY ETF
$27.15
$0.45
(1.69%)
Today
·
Closed $27.15
$0.05
(0.18%)
After Hours
1
3
0
1
3
0
Vol
213,338.00
52W High
$29.95
52W Low
$9.60
News
all
press releases
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Fourth-quarter revenue surged 43% to $19.3 billion, above Street estimates of $17.86 billion, according to Fiscal.ai data.
Stocktwits
Full Article
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
Full Article
<
...
1
>
Advertisement
|
Remove ads.
Latest LLYX News
View
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Stocktwits
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
Stocktwits
Loading...
Top Discussions
HIMS
$HIMS stock is tumbling today, reversing yesterday's rally, even after an FDA panel recommended adding several peptides to the compounding list. Are you buying the dip?
5
6
979 votes
SPY
What do you think the S&P 500's ($SPY) return will be next week?
33
65
9.7K votes
HIMS
The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for $HIMS. How do you think it goes?
5
2
524 votes
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile